Danish Investment Fund for Developing Countries, AKS Khan Pharmaceuticals to expand quality healthcare in Bangladesh
Through the Danish Investment Fund for Developing Countries (IFU), Denmark reaffirms its commitment to Bangladesh by making new strategic investments aimed at driving sustainable development.
A high level team from IFU in Denmark, including the CEO of IFU, Mr. Lars Bo Bertram, was in Bangladesh for the investment signing ceremony with AKS Khan Pharmaceuticals. Danish Ambassador to Bangladesh, H.E. Mr. Christian Brix Moller, also attended the signing ceremony and reaffirmed Denmark’s support to Bangladesh.
Denmark, a long-standing partner of Bangladesh since its independence, continues to show unwavering support for the country’s growth, the interim government, and its private sector.
On the occasion of the investment agreement signing, Danish Ambassador H.E. Mr Christian Brix Møller said, ´IFU´s investment is a statement of trust and confidence towards the private sector in Bangladesh, and also to the interim government, especially in a pivotal moment when Bangladesh has seen an uprising and is making efforts to rebuild the nation. ´
IFU’s latest investment in AKS Khan Pharmaceuticals, the first material investment in Bangladesh since KAFCO in 1990, focuses on the health care sector and supports the expansion of quality and accessible healthcare to the people of Bangladesh.
The IFU team also conducted a site visit to Saidabad Water Treatment Plant and called upon the Hon’ble Adviser for the Ministry of Industries and Hon’ble Adviser for the Ministry of Local Government, Rural Development and Co-operatives, discussing ongoing projects and scope of collaboration.
IFU confirms commitment to contribute to Bangladesh’s ambition to build a sustainable, green, and competitive economy, in line with global best practices.
Join Our Weekly Newsletter
Upcoming Events
Simillar News
Recent Random
Through the Danish Investment Fund for Developing Countries (IFU), Denmark reaffirms its commitment to Bangladesh by making new strategic investments aimed at driving sustainable development.
A high level team from IFU in Denmark, including the CEO of IFU, Mr. Lars Bo Bertram, was in Bangladesh for the investment signing ceremony with AKS Khan Pharmaceuticals. Danish Ambassador to Bangladesh, H.E. Mr. Christian Brix Moller, also attended the signing ceremony and reaffirmed Denmark’s support to Bangladesh.
Denmark, a long-standing partner of Bangladesh since its independence, continues to show unwavering support for the country’s growth, the interim government, and its private sector.
On the occasion of the investment agreement signing, Danish Ambassador H.E. Mr Christian Brix Møller said, ´IFU´s investment is a statement of trust and confidence towards the private sector in Bangladesh, and also to the interim government, especially in a pivotal moment when Bangladesh has seen an uprising and is making efforts to rebuild the nation. ´
IFU’s latest investment in AKS Khan Pharmaceuticals, the first material investment in Bangladesh since KAFCO in 1990, focuses on the health care sector and supports the expansion of quality and accessible healthcare to the people of Bangladesh.
The IFU team also conducted a site visit to Saidabad Water Treatment Plant and called upon the Hon’ble Adviser for the Ministry of Industries and Hon’ble Adviser for the Ministry of Local Government, Rural Development and Co-operatives, discussing ongoing projects and scope of collaboration.
IFU confirms commitment to contribute to Bangladesh’s ambition to build a sustainable, green, and competitive economy, in line with global best practices.